Non-UK Based Medical Device Manufacturers

Market access to the UK for medical devices is subject to regulatory requirements set by the UK Medicines and Healthcare products Regulatory Agency (MHRA) under the UK Medical Device Regulation (UK MDR).

To successfully gain market access, medical device manufacturers need to navigate the following key considerations:

• UK Responsible Person (UKRP): Manufacturers based outside of the UK must appoint a UKRP who will act as their representative and ensure compliance with the UK MDR. The UKRP plays a crucial role in overseeing regulatory compliance and interacting with the MHRA on behalf of the manufacturer.
• Conformity Assessment: Medical devices must undergo a conformity assessment process to demonstrate compliance with the UK MDR requirements. This typically involves conducting a conformity assessment procedure according to the relevant conformity assessment routes specified in the regulation.
• UK Conformity Assessed (UKCA) Marking: Medical devices placed on the UK market must bear the UKCA mark, which indicates compliance with the UK MDR. Manufacturers need to ensure that their devices are appropriately labelled with the UKCA mark and meet the applicable requirements for its use.
• Registration with the MHRA: Some classes of medical devices may require registration with the MHRA prior to placing them on the UK market. Manufacturers should carefully assess the regulatory requirements specific to their devices to determine if registration is necessary.
• Post-Market Surveillance: Manufacturers are required to establish post-market surveillance systems to monitor the safety and performance of their devices. This includes collecting and analyzing post-market data, responding to adverse events, and implementing appropriate corrective and preventive actions.
• Unique Device Identification (UDI): Compliance with UDI requirements, such as assigning and labelling devices with unique identifiers, is essential for market access. Manufacturers should ensure their devices meet the UDI requirements specified in the UK MDR.
• Clinical Evaluation and Evidence: Manufacturers must provide sufficient clinical evidence to demonstrate the safety and performance of their medical devices. This may involve conducting clinical studies, literature reviews, and post-market surveillance data analysis.
• Labelling and Instructions for Use: Medical device labelling and instructions for use should comply with the requirements set by the UK MDR. Manufacturers must ensure that their labelling provides accurate and comprehensive information for users and meets the specific requirements outlined by the regulation.
It is crucial for manufacturers to stay updated with the evolving regulatory landscape in the UK and to engage early with the MHRA and authorized bodies to ensure a smooth and compliant market access process. By adhering to the regulatory requirements and demonstrating the safety and effectiveness of their devices, manufacturers can successfully gain market access to the UK and contribute to improving patient care and healthcare outcomes.

Benefits of using our UK Responsible Person Service

We currently provide this service to many medical device clients globally so you can be assured of our support and expertise.

We can represent your medical or in-vitro device, evaluate Technical Files and respond directly to MHRA regarding any queries.

More information on UK RP Market access to the UK for medical devices is subject to regulatory requirements set by the UK Medicines and Healthcare products Regulatory Agency (MHRA) under the UK Medical Device Regulation (UK MDR).

To successfully gain market access, medical device manufacturers need to navigate the following key considerations:

• UK Responsible Person (UKRP): Manufacturers based outside of the UK must appoint a UKRP who will act as their representative and ensure compliance with the UK MDR. The UKRP plays a crucial role in overseeing regulatory compliance and interacting with the MHRA on behalf of the manufacturer.
• Conformity Assessment: Medical devices must undergo a conformity assessment process to demonstrate compliance with the UK MDR requirements. This typically involves conducting a conformity assessment procedure according to the relevant conformity assessment routes specified in the regulation.
• UK Conformity Assessed (UKCA) Marking: Medical devices placed on the UK market must bear the UKCA mark, which indicates compliance with the UK MDR. Manufacturers need to ensure that their devices are appropriately labelled with the UKCA mark and meet the applicable requirements for its use.
• Registration with the MHRA: Some classes of medical devices may require registration with the MHRA prior to placing them on the UK market. Manufacturers should carefully assess the regulatory requirements specific to their devices to determine if registration is necessary.
• Post-Market Surveillance: Manufacturers are required to establish post-market surveillance systems to monitor the safety and performance of their devices. This includes collecting and analyzing post-market data, responding to adverse events, and implementing appropriate corrective and preventive actions.
• Unique Device Identification (UDI): Compliance with UDI requirements, such as assigning and labelling devices with unique identifiers, is essential for market access. Manufacturers should ensure their devices meet the UDI requirements specified in the UK MDR.
• Clinical Evaluation and Evidence: Manufacturers must provide sufficient clinical evidence to demonstrate the safety and performance of their medical devices. This may involve conducting clinical studies, literature reviews, and post-market surveillance data analysis.
• Labelling and Instructions for Use: Medical device labelling and instructions for use should comply with the requirements set by the UK MDR. Manufacturers must ensure that their labelling provides accurate and comprehensive information for users and meets the specific requirements outlined by the regulation.

It is crucial for manufacturers to stay updated with the evolving regulatory landscape in the UK and to engage early with the MHRA and authorized bodies to ensure a smooth and compliant market access process. By adhering to the regulatory requirements and demonstrating the safety and effectiveness of their devices, manufacturers can successfully gain market access to the UK and contribute to improving patient care and healthcare outcomes.

Benefits of using our UK Responsible Person Service

We currently provide this service to many medical device clients globally so you can be assured of our support and expertise.

We can represent your medical or in-vitro device, evaluate Technical Files and respond directly to MHRA regarding any queries.

More information on UK RP can be found here.